Treatment Horizons

Treatment Horizons

FDA Approves New HIV Treatments

The U.S. Food and Drug Administration (FDA) has approved pharmaceutical giant Merck’s Delstrigo and Pifeltro for the treatment of HIV-1 infection in adult patients...

Dual Regimens in Trials Show Promise

The Power of Two Dual regimens show promise in clinical trials by Chael Needle At the International AIDS Conference in Amsterdam last July, ViiV Healthcare shared its...

An HIV Injectable Regimen Comes of Age

Without the Pill Box? The First Long-Acting Injectable Regimen for Individuals Living with HIV Comes of Age by Mel Baker A funny thing happened on the way to...

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...

LATEST POSTS

We Need to Bring Immune-Based HIV Therapies Off of the Sidelines

Dreaming of the Cells We Had We Need to Bring Immune-Based Therapies Off of the Sidelines by Jeannie Wraight For most people living with HIV, antiretrovirals (ARVs)...